Vesalio
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5800 Granite Pkwy Ste 470, Plano, Texas,...Phone Number
(615) 206-7788Website
www.vesalio.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Vesalio
Founded in 2013, Vesalio is a privately-held medical device company focused on advancing patient care in vascular occlusion by providing physicians with superior technology designed to improve clinical outcomes. Vesalio's proprietary NeVa platform is designed to consistently achieve first-pass recanalization in acute ischemic stroke by effectively removing all types of neurovascular clots from a patient's anatomy.Explore more
Vesalio Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vesalio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Vesalio
Check if Vesalio has recently received funding, and reach out quickly before it becomes old news!
Vesalio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Vesalio had a recent Job posting/layoffs
Earning: See what the market has to say on Vesalio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Vesalio has new funding data
Check out if Vesalio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Vesalio launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Vesalio
Compare insights from companies similar to Vesalio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vesalio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vesalio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vesalio.
Vesalio financials insights
Gather financial insights about Vesalio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Other Financing Round
$5M
Vesalio Tech Stack
A closer look at the technologies used by Vesalio
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Product Launch
Person-Based
Events
Person-Based
New Hire
Executive Move
Executive Moves, New Hire
Vesalio News & Media
NATURE Randomized Controlled Trial Meets Primary Endpoint Evaluating enVast-Assisted Mechanical Thrombectomy in Large-Thrombus STEMI
Results showed a reduction in infarct size compared with conventional PCI in STEMI patients with large thrombus burden. Results were presented as Late-Breaking Science at ESC Congress 2026. DALLAS, Texas, Aug. 29, 2026 /PRNewswire/ -- Vesalio today announced results from the NATURE trial...Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral Mechanical Thrombectomy Device with Integrated Distal Filter
New device expands Vesalio's pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval. DALLAS, Aug. 13, 2026 /PRNewswire/ -- Vesalio, a global leader in vascular intervention, today announced that the U.S. Food and Drug Administration (FDA)...Vesalio Announces Late-Breaking Clinical Trial Presentation of the enVast NATURE Study at the ESC Congress 2026
NATURE trial, a prospective randomized controlled trial comparing the safety and effectiveness of thrombectomy using enVast before conventional PCI versus standard of care alone, was selected for the prestigious Late-Breaking Clinical Trials session at the European Society of Cardiology...Vesalio Appoints Greg Cook as Chief Commercial Officer
Greg Cook joins Vesalio as Chief Commercial Officer to lead commercial strategy and execution across its thrombectomy platform. DALLAS, Texas, July 14, 2026 /PRNewswire/ -- Vesalio, a global leader in vascular intervention, is pleased to welcome Greg Cook as Chief Commercial Officer...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vesalio
Sign Up For FreeTo access detailed company insights
Founded in 2013, Vesalio is a privately-held medical device company focused on advancing patient care in vascular occlusion by providing physicians with superior technology designed to improve clinical outcomes. Vesalio's proprietary NeVa platform is designed to consistently achieve first-pass recanalization in acute ischemic stroke by effectively... Read More
